Evidence map›Paper›PMID 38751785›Full record

ArticleFrontiers in pharmacology2024

Unveiling the anticancer potential of the ethanolic extract from

Ana Carolina R Oliveira, Flávia Santiago De Oliveira, Ana Flávia Bráz, Jamil S Oliveira, Jane Lima-Santos, Adriana A M Dias

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ana Carolina R OliveiraLaboratory of Inflammation and Cancer, Department of Genetics, Ecology and Evolution, Institute of Science Biological, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Flávia Santiago De OliveiraLaboratory of Inflammation and Cancer, Department of Genetics, Ecology and Evolution, Institute of Science Biological, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Ana Flávia BrázLaboratory of Inflammation and Cancer, Department of Genetics, Ecology and Evolution, Institute of Science Biological, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Jamil S OliveiraPhysical Chemistry of Proteins and Enzymology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Jane Lima-SantosLaboratory of Immunobiology, Department of Biological Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil.
Adriana A M DiasLaboratory of Inflammation and Cancer, Department of Genetics, Ecology and Evolution, Institute of Science Biological, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The discovery of new therapeutic alternatives for cancer treatment is essential for improving efficacy and specificity, overcoming resistance, and enabling a more personalized approach for each patient. We investigated the antitumor activity of the crude ethanolic extract of the fungus

Indexed as

anticancerantineoplastic actioncytotoxicitydrug discoverysynergism, cancerTrichodermaTrichoderma asperelloides

Identifiers

PMID38751785
PMCPMC11094271

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.